![](/img/cover-not-exists.png)
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC
Pinto, Carmine, Normanno, Nicola, Orlandi, Armando, Fenizia, Francesca, Damato, Angela, Maiello, Evaristo, Tamburini, Emiliano, Di Costanzo, Francesco, Tonini, Giuseppe, Bilancia, Domenico, Corsi, DomJournal:
Future Oncology
DOI:
10.2217/fon-2017-0592
Date:
May, 2018
File:
PDF, 1.41 MB
2018